- The Novovax nanoparticle COVID-19 vaccine appeared to be safe, and elicited immune responses that exceeded levels in convalescent serum, in randomized, placebo-controlled, phase 1–2 trial. (NEJM, 2 September 2020) https://www.nejm.org/doi/full/10.1056/nejmoa2026920 63 comments science
Linking pages
- mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants | Scientific Reports https://www.nature.com/articles/s41598-022-06629-2 1849 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2107659?query=featured_home 4 comments
- Track COVID-19 Vaccines Advancing Through Clinical Trials | The Scientist Magazine® https://www.the-scientist.com/news-opinion/covid-19-vaccine-frontrunners-67382 3 comments
- Biology | Free Full-Text | COVID-19 Vaccines: Current Conditions and Future Prospects https://www.mdpi.com/2079-7737/10/10/960/htm 0 comments
- Let's unclog the FDA and save lives! - by Dan Elton https://danelton.substack.com/p/lets-unclog-the-fda-and-save-lives 0 comments
- Novavax coronavirus vaccine is safe, elicits immune response | CNN https://edition.cnn.com/2020/09/02/health/novavax-vaccine-safe/index.html 0 comments
Linked pages
Related searches:
Search whole site: site:doi.org
Search title: Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine | NEJM
See how to search.